Drug · DIN 02460947
CASPOFUNGIN FOR INJECTION
SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 27, 2026; first marketed April 19, 2017.
- Drug Identification Number (DIN)
- 02460947
- Company (DIN owner)
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Caspofungin J02AX04
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CASPOFUNGIN (CASPOFUNGIN ACETATE) | 50 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 27, 2026: NOC 37404Abbreviated New Drug Submission (ANDS) · Administrative: Merger/Buy-out
- December 20, 2023: NOC 32386Supplement to an Abbreviated New Drug Submission (SANDS) · Update to Labels
- May 25, 2021: NOC 25911Abbreviated New Drug Submission (ANDS) · Updates to labelling materials. manufacturer name change
- April 18, 2017: NOC 19171Abbreviated New Drug Submission (ANDS)
Other DINs named CASPOFUNGIN FOR INJECTION
- DIN 02460955 · Marketed
- DIN 02486989 · Marketed
- DIN 02486997 · Marketed